Physician profile

Lance C Lamotte

Interventional Cardiology · Baton Rouge, LA

NPI 1801856489

$23,738.54

in general payments reported to CMS, 2019-2025

45 companies · $4,244 in 2025

The $4,244 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,493.62
Travel and Lodging$5,238.40

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $3,870.33 2019-2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia
Medtronic, INC. $3,341.32 2021-2025 Corevalve Evolut R, Symplicity G3, Plasmablade(Tm)
Abiomed $2,643.17 2019-2025 Impella
Abbott Laboratories $2,542.56 2020-2025 Amplatzer Talisman, Amplatzer Amulet, Thoratec Heartmate 3 Lvas Implant Kit
Angiodynamics, INC. $2,088.25 2023-2024 Angiovac
Boston Scientific Corporation $1,319.76 2019-2025 Watchman Access System, Watchman Flx, General - Balloon Catheters
Medtronic Vascular, INC. $1,112.30 2019-2020
Shockwave Medical, INC $965.77 2022-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Baylis Medical Company INC $764.95 2021
Novartis Pharmaceuticals Corporation $700.98 2019-2025
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $505.86 2019-2025 Lifevest
Pfizer INC. $486.74 2019-2025
Artivion, INC. $448.96 2019
Amgen INC. $410.98 2019-2023 Repatha
Janssen Pharmaceuticals, INC $371.31 2019-2023 Xarelto
Show all 45 companies
CompanyGeneral paymentsYearsTop products
Alnylam Pharmaceuticals INC. $234.60 2022-2024 Onpattro
Astrazeneca Pharmaceuticals LP $227.82 2019-2023 Farxiga
Baxter Healthcare $191.88 2023-2025 Hillrom - Carnation Ambulatory Monitor
Merck Sharp & Dohme LLC $137.19 2021-2025 Verquvo, Capvaxive
Cardiovascular Systems INC. $135.75 2019-2023 Diamondback Coronary
Boehringer Ingelheim Pharmaceuticals, INC. $134.31 2019-2024 Jardiance
Novo Nordisk INC $132.68 2023-2025 Ozempic, Rybelsus, Wegovy
Impulse Dynamics (USA) INC. $105.97 2022-2023 Optimizer
Kowa Pharmaceuticals America, INC. $83.32 2019-2021
Irhythm Technologies, INC. $82.94 2023 Zio Xt Patch
E.R. Squibb & Sons, L.L.C. $70.28 2019-2022
Amarin Pharma, INC. $67.65 2020-2021
Cvrx, INC. $67.19 2023 Barostim Neo System
Arbor Pharmaceuticals, INC. $53.11 2019-2021
Sanofi-Aventis U.S. LLC $50.80 2019
Esperion Therapeutics, INC. $48.27 2020-2021
Vifor Pharma, INC. $46.93 2020-2021
Silk Road Medical, INC. $46.54 2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Kestra Medical Technology Services, INC. $37.01 2022
Regeneron Healthcare Solutions, INC. $31.10 2019
Lundbeck LLC $24.67 2020
Scpharmaceuticals INC. $21.13 2023
Cardiva Medical, INC. $20.53 2023 Cardiva Vascade Mvp Vvcs 6-12f
Kiniksa Pharmaceuticals, LTD. $19.80 2023 Arcalyst
Actelion Pharmaceuticals US, INC. $18.86 2025 Uptravi
Azurity Pharmaceuticals, INC. $17.53 2023 Edarbi
Bayer Healthcare Pharmaceuticals INC. $16.41 2023
Terumo Medical Corporation $14.04 2023 Glidewire, Optitorque, Tr Band
Atricure, INC. $14.02 2020
Biotronik INC. $12.97 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Lance C Lamotte

$23,738.54

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $4,244 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/217319/lance-c-lamotte

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.